Prophylactic for Endemic Diarrheal Diseases
Abstract
Demonstrate bacterial diarrheal prophylactic candidate safety, effectiveness, and pharmacokinetics through clinical trials in humans. Transition the prophylactic candidate to product developer in support of future FDA licensure.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2022
- Source ID
- a4138d224d775358530d2c4ca24b99b9